Navigation Links
Anemia from Malaria Linked to a Protein MIF

Scientists at Johns Hopkins, Yale and other institutions have conducted a joint cell and animal study that has revealed one important contributor to the severe anemia// that result from malaria, often causing death.

The culprit is a protein cells make in response to inflammation called MIF, which appears to suppress red blood cell production in people whose red blood cells already are infected by malaria parasites.

The parasite that causes malaria - known as plasmodium - is carried through blood by mosquito bites, and in parts of the world where mosquitoes thrive, millions are infected, most of them by early childhood. Once in the bloodstream, plasmodium invades liver and red blood cells and makes more copies of itself. Eventually, as red cells break and free plasmodium to infect other cells, and as the body's immune system works to kill infected cells, the total number of red blood cells drops, causing anemia.

But not everyone infected with malaria develops severe, lethal anemia. And there are cases where patients who have been cured of infection still develop severe anemia. This report provides the rationale for a simple, genetic test to sort out which children may be most susceptible to this lethal complication of malarial infection and to identify treatments targeted to them especially, the study's authors suggest.

"This is important because in places where malaria is endemic, drug treatment resources are scarce," says the study's primary author, Michael A. McDevitt, M.D., Ph.D., an assistant professor of medicine and hematology at the Johns Hopkins School of Medicine.

"There are many difficulties with blood transfusion safety and access in Africa, especially in rural areas where most of the malaria-related deaths occur," says McDevitt. "That led us to search for a better way to identify those most at risk and a better way to treat the disease," he says. The study, published online April 24 in the Journal of E
'"/>




Page: 1 2 3

Related medicine news :

1. Anemia may Lead to Physical Decline
2. Anemia Treatment for Cancer Patients
3. Anemia Treatment for Cancer Patients
4. Anemia Treatment for Cancer Patients Might Not be a Good Idea.
5. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
6. Treatment of Sickle Cell Anemia Using Gene Therapy.
7. Treating Sickle Cell Anemia using Healthy Stem Cells
8. EPO Effective For Cancer Patients Suffering From Anemia
9. Amgen introduces Autoinjector For Treating Anemia
10. Anemia Affects Both Body and Mind
11. Exercise alleviates Anemia in Breast cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Anemia from Malaria Linked Protein MIF

(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...olluted by manmade toxic chemicals and industrial ...etes risk, a new study shows. // Until now, obesit...he development of type 2 diabetes - a disorder in ...duce enough insulin - necessary for the body to be...
...ts are now looking at lactate with a much more pos...fuel” for the brain in the immediate //hours after...current standard. If they are right, it could chan...re physicians treat patients with brain injuries i...
...e Former Miss India Nikita Anand and Bollywood act...ged their organs for donation at the Army Research...ds of people suffering from organ dysfunction can ... trying to help people especially our three servic...
...ogonadism may result in erectile dysfunction, decr...e mineral loss, and the metabolic syndrome.// Whi...r its association with osteoporosis, the impact of...hysical functioning and fall risk has not been pro...
Other Medicine News:Health News:Study Challenges Conventional Treatment of Traumatic Brain Injury 2Health News:Indian Army Join to Add Strength to the Cadaver Programme 2Health News:Low Serum Testosterone Levels Associated With Fall Risk in Elderly Men 2
(Date:10/9/2008)...al Results Expected in November 2008, BOTHELL, Wa..., Inc.,(Amex: DDD ) announced today the completio...f its three pivotal trials to evaluate the safety ...d-release (ER) ibuprofen for,the over-the-counter ...ne,results from this pivotal trial in November 200...
(Date:10/8/2008)...Someday Inform Treatments for Spinal Cord, Other N...-USNewswire/ -- A protein that enables,nerve cells...n controlling,the developing nervous system. Resea...s to form among nerve cells may provide a basis fo...ries to their nervous system,including spinal cor...
(Date:10/8/2008)...Confirm Potency of Poly-ICR as Vaccine Adjuvant, ... Biopharmaceuticals,Corporation (TSX: NVN) today p...ing its proprietary Toll-like Receptor 3 agonist, ...cine Congress 2008 in Lyon, France.,Study results ...ant,targeting the Toll-like Receptor 3 (TLR3) path...
(Date:10/7/2008)... efficacy of new device for detecting polyps that ...copy, ORLANDO, Fla., Oct. 7 /- At th...ntific Meeting in Orlando (ACG 2008), renowned,gas...ts from a,multi-institutional clinical study that ...ope(R), a new device that is designed to improve t...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Preeclampsia Linked to Heart Disease Risk 5393 1Preeclampsia Linked to Heart Disease Risk 5393 2Preeclampsia Linked to Heart Disease Risk 5393 3Cornell will host the Northeast Biofuel Summit Nov 11 13 1087 1Mannatech Hosts Australasian Convention 5389 1Mannatech Hosts Australasian Convention 5389 2Mannatech Hosts Australasian Convention 5389 3American Medical Womens Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening 5386 1American Medical Womens Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening 5386 2American Medical Womens Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening 5386 3
... 8, 2007 - Late-breaking Phase III,clinical trial ...ety on Thrombosis and Haemostasis (ISTH) Congress ...uperior efficacy in the,prevention of venous throm...cement surgery in a head-to-head comparison with,e...in the RECORD3,(REgulation of Coagulation in major...
...ess with Positive Phase IIa Clinical,Trial Results...lication of Key,Product in AM-Pharma,s Pipeline , ...V., the,biopharmaceutical company developing novel... diseases, today announced the positive,clinical r...trial,for patients with ulcerative colitis, a chro...
Other Medicine Technology:Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 2AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 3AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 4AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 5
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: